TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
Bio Visjon AS
Closing information (x1000 SEK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
19,863
|
18,213
|
18,802 |
| Financial expenses |
201
|
34
|
11 |
| Earnings before taxes |
938
|
1,219
|
1,785 |
| Total assets |
15,009
|
15,990
|
16,042 |
| Current assets |
6,555
|
6,900
|
6,748 |
| Current liabilities |
5,778
|
2,706
|
3,539 |
| Equity capital |
3,575
|
2,894
|
2,081 |
| - share capital |
97
|
99
|
106 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
23.8%
|
18.1%
|
13.0% |
| Turnover per employee | |||
| Profit as a percentage of turnover |
4.7%
|
6.7%
|
9.5% |
| Return on assets (ROA) |
7.6%
|
7.8%
|
11.2% |
| Current ratio |
113.4%
|
255.0%
|
190.7% |
| Return on equity (ROE) |
26.2%
|
42.1%
|
85.8% |
| Change turnover |
1,973
|
656
|
-4,480 |
| Change turnover % |
11%
|
4%
|
-19% |
| Chg. No. of employees | |||
| Chg. No. of employees % |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.